NCT03031535 - Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions

Healthy Volunteer Study

Interventions

DRUG

Intranasal octreotide acetate

Intranasal spray of octreotide acetate

DRUG

Subcutaneous octreotide acetate

Subcutaneous injectable solution of octreotide acetate

DIAGNOSTIC_TEST

Growth hormone-releasing hormone

Part of the well established GHRH/Arginine challenge to detect GH deficiency.

DIAGNOSTIC_TEST

Arginine hydrochloride

Part of the well established GHRH/Arginine challenge to detect GH deficiency.

Trial Locations (1)

Celerion, Inc., Tempe